Literature DB >> 29877952

Pathophysiology, Diagnosis, and Management of Chronic Intestinal Pseudo-Obstruction.

Thomas J Downes1, Manikandar S Cheruvu1, Tennekoon B Karunaratne2, Roberto De Giorgio3, Adam D Farmer1,4,5.   

Abstract

Chronic intestinal pseudo-obstruction (CIPO) is a rare disorder characterized by an impairment of coordinated propulsive activity in the gastrointestinal (GI) tract, which clinically mimics mechanical intestinal obstruction. CIPO is the most severe and debilitating form of GI dysmotility. CIPO may be primary or be secondary to pathology at any level of the brain-gut axis as well as systemic disease. The clinical features of CIPO are pleomorphic and largely depend on the site and extent of the segment of the GI tract involved. The diagnostic approach includes the need for investigations to exclude mechanical GI obstruction, screening for causes of secondary CIPO and the identification of the disease phenotype as well as the prompt recognition and treatment of complications such as malnutrition and small intestinal bacterial overgrowth. In managing this disorder, a holistic, multidisciplinary approach is needed with judicious use of pharmacotherapeutic agents. While currently there are no specific therapeutic modalities for CIPO, treatment is largely directed at maintaining adequate nutrition and electrolyte balance and enhancing coordinated GI motility. Surgery should be avoided unless advisable for carefully selected patients and may include stoma formation. This narrative review provides a concise overview of the literature on this rare, severe and complex disorder, and highlights the need and areas for further research to improve both diagnostics and therapeutics.

Entities:  

Mesh:

Year:  2018        PMID: 29877952     DOI: 10.1097/MCG.0000000000001047

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  13 in total

1.  Recurrent arginine substitutions in the ACTG2 gene are the primary driver of disease burden and severity in visceral myopathy.

Authors:  Nurit Assia Batzir; Pranjali Kishor Bhagwat; Austin Larson; Zeynep Coban Akdemir; Maciej Bagłaj; Leon Bofferding; Katherine B Bosanko; Skander Bouassida; Bert Callewaert; Ashley Cannon; Yazmin Enchautegui Colon; Adolfo D Garnica; Margaret H Harr; Sandra Heck; Anna C E Hurst; Shalini N Jhangiani; Bertrand Isidor; Rebecca O Littlejohn; Pengfei Liu; Pilar Magoulas; Helen Mar Fan; Ronit Marom; Scott McLean; Marjan M Nezarati; Kimberly M Nugent; Michael B Petersen; Maria L Rocha; Elizabeth Roeder; Robert Smigiel; Ian Tully; James Weisfeld-Adams; Katerina O Wells; Jennifer E Posey; James R Lupski; Arthur L Beaudet; Michael F Wangler
Journal:  Hum Mutat       Date:  2019-12-19       Impact factor: 4.878

Review 2.  Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility.

Authors:  Edoardo Savarino; Fabiana Zingone; Brigida Barberio; Giovanni Marasco; Filiz Akyuz; Hale Akpinar; Oana Barboi; Giorgia Bodini; Serhat Bor; Giuseppe Chiarioni; Gheorghe Cristian; Maura Corsetti; Antonio Di Sabatino; Anca Mirela Dimitriu; Vasile Drug; Dan L Dumitrascu; Alexander C Ford; Goran Hauser; Radislav Nakov; Nisha Patel; Daniel Pohl; Cătălin Sfarti; Jordi Serra; Magnus Simrén; Alina Suciu; Jan Tack; Murat Toruner; Julian Walters; Cesare Cremon; Giovanni Barbara
Journal:  United European Gastroenterol J       Date:  2022-06-13       Impact factor: 6.866

3.  Pediatric Intestinal Pseudo-Obstruction: Progress and Challenges.

Authors:  Marie-Catherine Turcotte; Christophe Faure
Journal:  Front Pediatr       Date:  2022-04-13       Impact factor: 3.569

4.  Enteric neuron density correlates with clinical features of severe gut dysmotility.

Authors:  Elisa Boschetti; Carolina Malagelada; Anna Accarino; Juan R Malagelada; Rosanna F Cogliandro; Alessandra Gori; Elena Bonora; Fiorella Giancola; Francesca Bianco; Vitaliano Tugnoli; Paolo Clavenzani; Fernando Azpiroz; Vincenzo Stanghellini; Catia Sternini; Roberto De Giorgio
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-23       Impact factor: 4.052

Review 5.  The enteric nervous system in gastrointestinal disease etiology.

Authors:  Amy Marie Holland; Ana Carina Bon-Frauches; Daniel Keszthelyi; Veerle Melotte; Werend Boesmans
Journal:  Cell Mol Life Sci       Date:  2021-03-26       Impact factor: 9.261

Review 6.  Visceral myopathy: clinical syndromes, genetics, pathophysiology, and fall of the cytoskeleton.

Authors:  Sohaib Khalid Hashmi; Rachel Helen Ceron; Robert O Heuckeroth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-03-17       Impact factor: 4.871

Review 7.  Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment.

Authors:  Luísa Leite Barros; Alberto Queiroz Farias; Ali Rezaie
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

Review 8.  Anti-CV2/CRMP5 antibody-positive paraneoplastic neurological syndromes with chronic intestinal pseudo-obstruction in a small-cell lung cancer patient: a case report and literature review.

Authors:  Jinhua Yan; Zhongbo Chen; Yumei Liang; Huijia Yang; Lizhi Cao; Yuling Zhou; Yang Zhao; Ying Zhang
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

9.  Clinical Outcomes of Pediatric Chronic Intestinal Pseudo-Obstruction.

Authors:  Dayoung Ko; Hee-Beom Yang; Joong Youn; Hyun-Young Kim
Journal:  J Clin Med       Date:  2021-05-28       Impact factor: 4.241

Review 10.  Chronic Intestinal Pseudo-Obstruction: Is There a Connection with Gut Microbiota?

Authors:  Giulia Radocchia; Bruna Neroni; Massimiliano Marazzato; Elena Capuzzo; Simone Zuccari; Fabrizio Pantanella; Letizia Zenzeri; Melania Evangelisti; Francesca Vassallo; Pasquale Parisi; Giovanni Di Nardo; Serena Schippa
Journal:  Microorganisms       Date:  2021-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.